PARCS 2027 – Scientific Program Directed by Dr Alain Tenenbaum

PARCS 2027 – São Paulo

The 10th International Conference on Plastic Aesthetic, Reconstructive Surgery & Regenerative Medicine will take place on 23–24 April 2027 in São Paulo, Brazil.

Scientific direction

The scientific program is being developed under the direction of Dr Alain Tenenbaum, Scientific Program Director. Dr Tenenbaum will contribute to the development of the scientific sessions, the selection of invited medical speakers and the moderation of selected sessions.

His role is strictly scientific. The organization, sponsorship, finances, registration, accommodation and event logistics are managed independently by the official congress organizer.

Scientific scope

The planned scientific themes include:

• Plastic, aesthetic and reconstructive surgery
• Facial plastic surgery
• Cosmetic dermatology and aesthetic medicine
• Regenerative medicine
• Minimally invasive procedures
• Emerging technologies and clinical innovations

Important information

The detailed scientific program, confirmed faculty, congress hotel and venue information are still under development. This page will be updated as verified information becomes available.

Registration

Participant registration and all related payments are handled exclusively through the official PARCS 2027 website. Aesthetic.events does not collect registration fees and is not responsible for cancellations, accommodation or congress logistics.

Event Properties

Event Date	23-04-2027 9:00 am
Event End Date	24-04-2027 7:00 pm
Cut off date	24-04-2027 7:00 pm
Individual Price	Registration through the official PARCS 2027 website.
Speaker	Dr Alain Tenenbaum
Location	SAO PAULO
Categories	Congresses, All Events

Speakers

Dr. Alain Tenenbaum

Founder & Medical Director – Myomodulation & Metabolic Peels

International Medical Faculty

Facial Plastic Surgery · Myomodulation · Metabolic Peels · Artificial Intelligence

Dr Alain Tenenbaum

MD, PhD, DSc (Hon.)

Facial plastic surgeon, researcher, author and international medical educator. Founder of Myomodulation, developer of three-dimensional isovolumetric chemical myoplasty, inventor of Endopeel®, and developer of metabolic chemical peel protocols. Dr Alain Tenenbaum is also an expert in artificial intelligence applied to aesthetic medicine, medical communication and high-end digital medical ecosystems.

Myomodulation Chemical Myoplasty Metabolic Peels Artificial Intelligence

Professional Overview

Facial plastic surgeon, researcher, author and international medical educator.
Founder and Medical Director of Myomodulation.
Founder of three-dimensional isovolumetric chemical myoplasty for functional and aesthetic muscle modulation.
Inventor of Endopeel® and developer of metabolic chemical peel protocols.
International expert in facial aesthetics, body contouring, chemical peeling and complication management.
Expert in artificial intelligence applied to aesthetic medicine, medical education and medical communication.
Expert in digital medical strategy, premium medical websites, applications and high-end medical web ecosystems.
Former Swiss National Delegate to the European Academy of Facial Plastic Surgery.
Former Webmaster of EAFPS.org.
Former Webmaster for the Aesthetic Medicine Section of the Royal Society of Medicine, London.

Academic Degrees & Distinctions

Doctor of Medicine – MD.
Doctor PhD – PhD.
Doctor of Science – DSc.
Doctor Honoris Causa in Sciences – Henan University, China.
Former Associate Professor of Plastic Surgery – Zhengzhou, China.
Former Associate Professor of Medical Informatics – Faculty of Medicine of Nancy, France.
Silver Medal – Faculty of Medicine, University of Paris.

Medical & Scientific Training

ENT and Facial Plastic, Reconstructive & Cosmetic Surgery – Paris.
Aerospace and Aviation Medicine.
Biological Physical Chemistry.
Biophysics.
Biomathematics and Biostatistics.

Scientific Innovations & Contributions

Founder of Myomodulation.
Developer of three-dimensional isovolumetric chemical myoplasty.
Developer of non-surgical functional muscle projection and body-contouring protocols.
Inventor of Endopeel®.
Developer of metabolic chemical peel protocols.
International lecturer in chemical peels, facial aesthetics, body contouring and functional muscle modulation.
International authority on complications associated with fillers and implants.

Leadership & International Roles

University Lecturer in Chemical Peels and Myomodulation – University Diploma in Aesthetic Medicine, Paris.
Former President – SACDAM.
Former President – International Peelings Society.
Former Swiss National Delegate – European Academy of Facial Plastic Surgery.
Former Webmaster – EAFPS.org.
Former Webmaster – Aesthetic Medicine Section, Royal Society of Medicine, London.
Member of the FMH, EAFPS and international scientific societies.

Current Medical, Scientific & AI Expertise

Myomodulation

Functional muscle modulation and three-dimensional isovolumetric chemical myoplasty.

Body Contouring

Male and female non-surgical gluteoplasty and isovolumetric muscle projection.

Metabolic Peels

Metabolic chemical peeling, epidermal integrity and skin barrier preservation.

Complication Management

Prevention and management of complications associated with fillers, implants and aesthetic procedures.

Artificial Intelligence

AI strategy, AI-assisted medical communication, knowledge architecture and intelligent medical digital ecosystems.

Medical Digital Strategy

Medical SEO, website architecture, medical applications, premium domains and high-end clinical web ecosystems.

Current positioning: Myomodulation represents Dr Alain Tenenbaum’s principal contemporary scientific and clinical platform. Endopeel® remains referenced as an original invention and an important historical contribution to his professional and scientific career.

Mauro Tiziani

Scientific Director & Lead Instructor – Endopeel®

Mauro Tiziani is the Scientific Director and co-developer of the Endopeel® concept. His work focuses on biochemical mechanisms, tissue response, and molecular aspects of metabolic stimulation. He is responsible for research orientation, scientific validation, and advanced clinical protocols. Mauro Tiziani is actively involved in instructor-level training and clinical strategy development.